Description: Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Home Page: www.enovis.com
2711 Centerville Road
Wilmington,
DE
19808
United States
Phone:
302 252 9160
Officers
| Name | Title |
|---|---|
| Mr. Matthew L. Trerotola | CEO & Chairman |
| Mr. Phillip Benjamin Berry | Senior VP & CFO |
| Ms. Patricia A. Lang | Senior VP & Chief Human Resources Officer |
| Mr. Daniel A. Pryor | Executive Vice President of Strategy & Business Development |
| Mr. Brady R. Shirley | Executive Advisor & Director |
| Mr. John Kleckner | VP, Controller & Chief Accounting Officer |
| Mr. Derek Leckow J.D. | Vice President of Investor Relations |
| Mr. Bradley J. Tandy J.D. | Senior VP & Chief Legal Officer |
| Katie Sweet | Vice President of Corporate Communication |
| Mr. Tim Czartoski | President of U.S. Surgical and Global Product & Enabling Technologies |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Industrials |
|---|---|
| GIC Group: | Capital Goods |
| GIC Industry: | Machinery |
| GIC Sub-Industry: | Industrial Machinery & Supplies & Components |
| Forward PE: | 15.2672 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.8027 |
| Price-to-Sales TTM: | 1.2714 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 6550 |